Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing G-POEM and PEG-J treatments for gastroparesis

Official title: 'Treatment Outcome of Gastric Peroral Endoscopic Pyloromyotomy in Comparison With Percutaneous Endoscopic Gastrostomy With Jejunal Extension in Medically Refractory Gastroparesis: a Prospective Randomized Controlled Trial'

Run by Maastricht University Medical Center · NCT06372132 · Data updated 2026-11-12

This study is testing whether a new procedure called G-POEM or a feeding tube method called PEG-J can help people with stubborn gastroparesis feel better.

More Gastroparesis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorMaastricht University Medical Center
Academic / other
Locations1 site (Maastricht, Zuid-Limburg)
StatusRecruiting
StartedMarch 14, 2024
Main results expectedJanuary 2027
Study endsJanuary 1, 2028
Registry record updatedApril 17, 2024
Trial IDNCT06372132 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with diagnosed gastroparesis who have not responded to conventional therapies.

Probably not a fit

Patients under 18, those with a history of specific stomach surgeries, or current opioid users may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of two treatment options, G-POEM and PEG-J, for patients suffering from refractory gastroparesis. It involves a randomized, non-blinded controlled design with two groups: one receiving G-POEM and the other receiving PEG-J. Treatment success will be assessed using the Gastroparesis Cardinal Symptom Index (GCSI) at baseline and six months post-intervention, with a potential crossover after the follow-up period. The study aims to enroll 50 patients who have not responded to standard dietary and pharmacological treatments.

Why it matters

Potential benefit: If successful, this study could provide a new effective treatment option for patients with refractory gastroparesis.

How similar studies have gone: Other studies have shown promising results with G-POEM for gastroparesis, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with GP
* 13C octanoic acid test or gastric scintigraphy (minimal 4-hour measurement) within the past twelve months
* 18 years old

Exclusion Criteria:

* \< 18 years old
* Medical history of stomach surgery in which resection of antrum and/ or pylorus took place
* Medical history of surgical or laparoscopic pyloromyotomy
* Gastric bypass
* Current opioid use
* Pregnancy

Where it's running

  • Maastricht University Medical Center
    Maastricht, Zuid-Limburg, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.